Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KYNB
5951
CALL
Kyntra Bio
KYNB
$27.6M
| $1.57M | ﹤0.01% |
5,932
+4,488
| +311% | +$1.15M |
|
5952
CALL
Bausch + Lomb
BLCO
$6.07B
| $1.56M | ﹤0.01% |
+102,700
| New | +$1.66M |
|
5953
PUT
Emcor
EME
$38B
| $1.56M | ﹤0.01% |
15,200
+5,100
| +50% | +$545K |
|
5954
Northrim BanCorp
NRIM
$598M
| $1.56M | ﹤0.01% |
155,448
+100,628
| +184% | +$1.03M |
|
5955
Syntax Stratified LargeCap ETF
SSPY
$132M
| $1.56M | ﹤0.01% |
+25,807
| New | +$1.69M |
|
|
TGI
5956
DELISTED
Triumph Group
TGI
| $1.56M | ﹤0.01% |
117,690
-16,288
| -12% | -$309K |
|
5957
PUT
TG Therapeutics
TGTX
$7.54B
| $1.56M | ﹤0.01% |
368,100
-2,900
| -0.8% | -$18.1K |
|
|
FPAC
5958
CALL
DELISTED
Far Peak Acquisition Corporation
FPAC
| $1.56M | ﹤0.01% |
159,200
-60,100
| -27% | -$592K |
|
|
YELL
5959
DELISTED
Yellow Corporation Common Stock
YELL
| $1.56M | ﹤0.01% |
533,355
+124,287
| +30% | +$504K |
|
5960
PUT
Amplitude
AMPL
$1.58B
| $1.56M | ﹤0.01% |
109,300
-28,500
| -21% | -$500K |
|
|
HUT
5961
CALL
Hut 8
HUT
$10.9B
| $1.56M | ﹤0.01% |
234,580
+39,460
| +20% | +$589K |
|
5962
CALL
Brookfield Infrastructure Partners
BIP
$17.9B
| $1.56M | ﹤0.01% |
40,800
-19,950
| -33% | -$820K |
|
5963
CALL
Jack in the Box
JACK
$328M
| $1.56M | ﹤0.01% |
27,800
-3,100
| -10% | -$235K |
|
|
AZPN
5964
PUT
DELISTED
Aspen Technology Inc
AZPN
| $1.56M | ﹤0.01% |
+8,484
| New | +$1.51M |
|
5965
PUT
Insperity
NSP
$1.93B
| $1.56M | ﹤0.01% |
15,600
-4,500
| -22% | -$446K |
|
5966
John Hancock Multifactor Mid Cap ETF
JHMM
$6.21B
| $1.56M | ﹤0.01% |
35,228
+29,845
| +554% | +$1.44M |
|
5967
iShares MSCI Europe Small-Cap ETF
IEUS
$184M
| $1.55M | ﹤0.01% |
32,025
-34,480
| -52% | -$1.91M |
|
5968
iShares MSCI Agriculture Producers ETF
VEGI
$146M
| $1.55M | ﹤0.01% |
+39,649
| New | +$1.78M |
|
|
CHX
5969
DELISTED
ChampionX
CHX
| $1.55M | ﹤0.01% |
78,243
-288,645
| -79% | -$6.52M |
|
5970
BlackRock ESG Capital Allocation Term Trust
ECAT
$1.53B
| $1.55M | ﹤0.01% |
108,557
+12,565
| +13% | +$186K |
|
|
MGIC
5971
PUT
DELISTED
Magic Software Enterprises
MGIC
| $1.55M | ﹤0.01% |
87,400
+29,200
| +50% | +$500K |
|
|
DFND
5972
DELISTED
Siren DIVCON Dividend Defender ETF
DFND
| $1.55M | ﹤0.01% |
+46,324
| New | +$1.6M |
|
5973
PUT
Pacira BioSciences
PCRX
$926M
| $1.55M | ﹤0.01% |
26,600
-26,300
| -50% | -$1.72M |
|
5974
CALL
Prelude Therapeutics
PRLD
$449M
| $1.55M | ﹤0.01% |
297,200
+125,800
| +73% | +$640K |
|
5975
CALL
ENI
E
$80.9B
| $1.55M | ﹤0.01% |
65,100
+45,000
| +224% | +$1.28M |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.